Levitee Labs Inc.

LVT

CA5274241051

Food Processing

Market Closed - Canadian Securities Exchange Other stock markets 11:03:02 2023-02-01 am EST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2022	Levitee Labs Inc. Announces Executive Changes	CI
2022	Levitee Labs Inc. Announces CEO Changes	CI

Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of September and October 2021

November 08, 2021 at 04:00 pm EST

Levitee Labs Inc. announced consolidated revenue results for the month of September and October 2021. For the September and October 2021, the company reported revenue of $1,553,728 for the month of September and October 2021.

Latest news about Levitee Labs Inc.

Levitee Labs Inc. Announces Executive Changes	22-06-20	CI
Levitee Labs Inc. Announces CEO Changes	22-06-20	CI
Levitee Labs Inc. Announces Philip Van Den Berg to Join as Interim CEO	22-02-01	CI
Levitee Labs Inc. Announces Philip Van Den Berg to Join the Board of Directors	22-02-01	CI
Levitee Labs Inc. announced that it expects to receive CAD 3 million in funding	22-01-17	CI
Levitee Labs Inc Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals	22-01-12	CI
Levitee Labs Inc. Enters into A Strategic Partnership Via A Services Agreement with Canntab Therapeutics Limited	22-01-10	CI
Levitee Labs Inc. Appoints Maigul Wickham as its Chief Financial Officer Replacing Mason Darabi	22-01-06	CI
Levitee Labs Announces Medical Advisory Board	22-01-06	CI
Levitee Labs Inc. Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care Throughout Alberta, Canada	21-12-20	CI
Levitee Labs Inc. Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region	21-11-15	CI
Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of September and October 2021	21-11-08	CI
Levitee Labs to Seek Acquisitions	21-10-22	CI
Levitee?Labs Enters into Credit Facility For Up To $12 Million	21-10-21	CI
Levitee Labs Inc. announced that it expects to receive $12 million in funding	21-10-20	CI
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions	21-10-18	CI
Levitee Labs Appoints Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada	21-10-14	CI
Levitee Labs : Signs Letter of Intent to Acquire Calgary-Based Compounding Pharmacy	21-10-12	MT
Levitee Labs Inc. entered into a letter of intent to acquire 51% of the issued and outstanding shares in Compounding Pharmacy in Calgary, Alberta, Canada for CAD 0.306 million.	21-10-11	CI
Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of August 2021	21-10-05	CI
Levitee Labs : Canadian Wellness Company Levitee Labs Lists on Frankfurt Bourse	21-10-03	MT
Levitee Labs : Up 2.5% as Reports DTC Eligibility Approval	21-09-24	MT
Levitee Labs : Reports DTC Eligibility Approval	21-09-24	MT
Levitee Labs Inc. Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods	21-08-10	CI
Levitee Labs Appoints Fady Hannah-Shmouni as Chief Medical and Scientific Officer and President of Levitee Clinics and Pharmacies	21-08-05	CI

Chart Levitee Labs Inc.

Duration

Period

More charts

Company Profile

Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Companyâs portfolio of assets includes Levitee Clinics, Levitee Pharmacies, Levitee Nutraceuticals and Sporeo. Levitee Clinics is a group of five operating addiction and pain treatment clinics in Alberta. Levitee Pharmacies includes three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain. Levitee Nutraceuticals includes MONKE Nutra, Ojio, Earth Shift and Earth Circle Organics. Sporeo products are available through retail, wholesale, and ecommerce channels and defragments the mushroom cultivation ecosystem.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
LEVITEE LABS INC.	-.--%	393K
ZHEJIANG NHU COMPANY LTD.	+13.21%	8.15B
BELLRING BRANDS, INC.	+3.16%	7.52B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+12.30%	6.65B
BYHEALTH CO., LTD	-6.99%	3.72B
THE SIMPLY GOOD FOODS COMPANY	-5.71%	3.73B
XIAMEN KINGDOMWAY GROUP COMPANY	-4.78%	1.31B
SIRIO PHARMA CO., LTD.	+12.61%	972M
HERBALIFE LTD.	-37.22%	958M
USANA HEALTH SCIENCES, INC.	-15.02%	876M

Special Foods & Wellbeing Products

Levitee Labs Inc.

Equities

LVT

CA5274241051

Food Processing

Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of September and October 2021

Latest news about Levitee Labs Inc.

Chart Levitee Labs Inc.

Company Profile

Sector Special Foods & Wellbeing Products